TERN Terns Pharmaceuticals Inc.

Health Care, filed as TERNS PHARMACEUTICALS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

In 2026 Q2 Davidson Kempner Capital Management, George Soros, Ron Baron, and Farallon Capital Management sold out of Terns Pharmaceuticals.

Who owns TERN

Sorted by value, long equity only, as of 2026 Q2.

					History
George Soros, Soros Fund Management exited 2026 Q2 Last 2026 Q1	0.19%	Exit −0.19%	321,905	$17M	History
Davidson Kempner Capital Management exited 2026 Q2 Last 2026 Q1	0.22%	Exit −0.22%	311,623	$16M	History
Ron Baron, Bamco Inc. (Baron Capital) exited 2026 Q2 Last 2026 Q1	0.01%	Exit −0.01%	35,000	$1.8M	History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1	<0.01%	Exit 0.00%	7,000	$369K	History

0 current, 4 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

13Fs that reported it each quarter. Click a bar for that quarter’s holders.